Other Cancers Frailty Subgroup Analysis: KDD vs. KD in Relapsed/Refractory Multiple Myeloma (RRMM) May 29, 2023
Other Cancers 5-Year Follow-up of RESPONSE-2 Study: Ruxolitinib vs. Best Available Therapy for Polycythemia Vera May 29, 2023
Other Cancers ENLIVEN Trial Demonstrates Modest Pain Relief With Pexidartinib in TGCT Patients May 29, 2023
Other Cancers Comparison of DVRD Followed by Cilta-Cel v ASCT in Transplant-Eligible Patients With NDMM May 24, 2023
Other Cancers Long-term Safety and Survival of Momelotinib in Myelofibrosis: A Phase 3 Analysis May 24, 2023
